Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Something Cooking ? Or did the get tax refund cheques ?

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on May 06, 2021 12:57pm

558 Views

Post# 33141552

RE:Something Cooking ? Or did the get tax refund cheques ?

For those investors keeping an ear to the ground, the TLT story is still great!
It's clear, from the ease, efficacy, and cost-efficiency of treatment, that ours will soon be the go-to solution for bladder cancer.
Every patient will want to try it!
Market penetration should be swift, too, when word starts getting out.
Buy and hold on, longs,
and good luck!

Oden6570 wrote: Insider Buying (Last 12 Months):C$136,504.86Insider Selling (Last 12 Months):C$0.00

TLT Insider Trading Activity (Theralase Technologies)

I would like to see our CEO show sighns of life ! No buying ? No interviews ? No promotion ? Over one full year , crickets !

View from the C-Suite: Shawn Shirazi, Chief Executive Officer, Theralase Technologies Inc., tells his company's story. Filmed on December 18, 2019

As well what every happened to whackie Mackie ? That was then , well befor recent developments , Covid research , Theralase research centre , Phase 2 progression were are they and why such silence ? Is Mackie the ones responsible for share depression ?
At press time, Uddin’s $0.70 target represented a projected 12-month return of 268 per cent.
Theralase Technologies has a 256 per cent upside, says Mackie Research - Cantech Letter